Lecture 11. Section C (Week 3): Understanding Diseases of the Immune System

Similar documents
THE BIOLOGY OF CANCER. Dr Jim Edwards Medical Oncologist Canterbury District Health Board

oncogenes-and- tumour-suppressor-genes)

Deregulation of signal transduction and cell cycle in Cancer

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Biochemistry of Carcinogenesis. Lecture # 35 Alexander N. Koval

TUMOR M ARKERS MARKERS

609G: Concepts of Cancer Genetics and Treatments (3 credits)

Introduction to Basic Oncology

Chapter 9, Part 1: Biology of Cancer and Tumor Spread

Tumor Immunity and Immunotherapy. Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School

Overview of the core ideas in cancer research

Biology Based Cancer Interception

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Institute of Radiation Biology. Oncogenes and tumour suppressor genes DoReMi Course 2014

What causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)

New Developments in the Treatment of Colorectal Cancer. Jonathan Loree, MD, MS, FRCPC Department of Medical Oncology BC Cancer Vancouver Centre

Introduction to Cancer Bioinformatics and cancer biology. Anthony Gitter Cancer Bioinformatics (BMI 826/CS 838) January 20, 2015

Lecture 8 Neoplasia II. Dr. Nabila Hamdi MD, PhD

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

The History of Cancer

CELL BIOLOGY - CLUTCH CH CANCER.

CANCER Uncontrolled Cell Division

Cancer. Questions about cancer. What is cancer? What causes unregulated cell growth? What regulates cell growth? What causes DNA damage?

Introduction to Cancer Biology

The Hallmarks of Cancer

NEOPLASIA-I CANCER. Nam Deuk Kim, Ph.D.

BIT 120. Copy of Cancer/HIV Lecture

Inner Life of a Cell. Harvard Fall Video. ml

Information. about cancer

Computer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015

Activation of cellular proto-oncogenes to oncogenes. How was active Ras identified?

Neoplasia 2018 Lecture 1. Dr Heyam Awad MD, FRCPath

Neoplasia 2018 lecture 4. Dr Heyam Awad MD, FRCPath

Claudia Adams Barr Program in Innovative Cancer Research Dana-Farber Cancer Institute BARR PROGRAM IMPACT STATEMENTS

Chapter 4 Cellular Oncogenes ~ 4.6 -

Genetics of Cancer Lecture 32 Cancer II. Prof. Bevin Engelward, MIT Biological Engineering Department

Lecture 1: Carcinogenesis

Lecture 1: Carcinogenesis

Neoplasia 2018 lecture 11. Dr H Awad FRCPath

TUESDAY, 18th OCTOBER, 2016 / DAY -2. THE SPENCER HOTEL Hall A Hall B (St. Lukes Hospital)

Epidemiology in Texas 2006 Annual Report. Cancer

Present State of Gene Diagnosis and Future Prospects

Neoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)

mirna Dr. S Hosseini-Asl

Acute: Symptoms that start and worsen quickly but do not last over a long period of time.

MIRROR IMAGE MIRROR IMAGE. The future of cancer diagnostics may be closer than it appears

Section D. Genes whose Mutation can lead to Initiation

Cancer Cells. It would take another 20 years and a revolution in the techniques of biological research to answer these questions.

Molecular Cell Biology. Prof. D. Karunagaran. Department of Biotechnology. Indian Institute of Technology Madras

Cancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz October 11, 2013

Lecture 1: Course Introduction and Cancer ʻby the Numbersʼ. biochemistry 4450a

Oncology 101. Cancer Basics

Mohammed El-Khateeb. Tumor Genetics. MGL-12 May 13 th Chapter 22 slide 1 台大農藝系遺傳學

Current and Future Treatment Options for Glioblastoma

Tumor Immunology. Tumor (latin) = swelling

BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

3 rd Berlin Cancer Retreat - Agenda

Pathology of Inflammatory Breast Cancer (IBC) A rare tumor

Karyotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl

Cancer arises from the mutation of a normal gene. A factor which brings about a mutation is called a mutagen.

Abdulrahman Alhanbali. Bahaa Najjar. Maha shomaf

Cell Cycle and Cancer

EBV infection B cells and lymphomagenesis. Sridhar Chaganti

Aberrant cell Growth. Younas Masih New Life College of Nursing Karachi. 3/4/2016 Younas Masih ( NLCON)

Part I. An Introduction to Cancer

Genetics and Cancer Ch 20

BASIC MECHANISM OF TUMOR IMMUNE SUPPRESSION

Cancer and Gene Alterations - 1

number Done by Corrected by Doctor Maha Shomaf

Glioblastoma pathophysiology: or a

number Done by Corrected by Doctor مها شوماف

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber

Introduction to Genetics

Mohammed El-Khateeb. Tumor Genetics. MGL-12 July 21 st 2013 台大農藝系遺傳學 Chapter 22 slide 1

Recent Advances in Cancer Research and Therapeutic Approaches. Leonidas C. Platanias, MD, PhD

Cancer and Gene Regulation

Understanding Tumor Markers for Breast and Colorectal Cancers. A Patient s Guide. Recommendations of the American Society of Clinical Oncology

TUESDAY, 18th OCTOBER, 2016 / DAY -2

34 Cancer. Lecture Outline, 11/30/05. Cancer is caused by mutant genes. Changes in growth properties of cancer cells

Chapter 10-3 Regulating the Cell Cycle

A class of genes that normally suppress cell proliferation. p53 and Rb..ect. suppressor gene products can release cells. hyperproliferation.

Cancer Epidemiology, Manifestations, and Treatment

MOLECULAR BASIS OF ONCOGENESIS

Melatonin and its Role in the Inhibition of Breast Cancer Ciara Nicol Ross Copyright 2014 by Ciara Ross and Koni Stone

HIV AND INFLAMMATION: A NEW THREAT

COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16

Exploring Immunotherapies: Beyond Checkpoint Inhibitors

Molecular Biology of Cancer. Code: ECTS Credits: 6. Degree Type Year Semester

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Checkpoint Regulators Cancer Immunotherapy takes centre stage. Dr Oliver Klein Department of Medical Oncology 02 May 2015

Howard Temin. Predicted RSV converted its genome into DNA to become part of host chromosome; later discovered reverse transciptase.

Cell Death and Cancer. SNC 2D Ms. Papaiconomou

A holistic approach to targeting breast cancer part II: Micronutrient synergy. Presented by: Dr. Neha Shanker DRRI

Overview of Cancer. Mylene Freires Advanced Nurse Practitioner, Haematology

Molecular Biology of Cancer. Code: ECTS Credits: 6. Degree Type Year Semester

Asexual Reproduction & Cancer

Bihong Zhao, M.D, Ph.D Department of Pathology

Biological Therapies for Cancer: Questions and Answers

Transcription:

Lecture 11 Section C (Week 3): Understanding Diseases of the Immune System 11. Why can t the immune system fight cancer? 12. Understanding immune system function as you get older? 13. How has the immune system been described in Hollywood movies? 14. What is next in the understanding of the immune system? 15. Open discussion and wrap up

Origin of the word Cancer... It was first documented by the Greek physician, Hippocrates (460 370 BC) by using the words karkinos and carcinoma to describe non-ulcer and ulcer forming tumours, respectively It was later translated into Latin by the Roman physician, Celsus (28 50 BC) to cancer, the Latin word for crab Hippocrates described cancer as similar in appearance to the finger-like projections of a crab The Roman physician, Galen (130 300 AD) used the word oncos to describe the observed tumours. Oncos is the Greek word for swelling During the Renaissance period leading into the 19 th century, human diseases were studied in a more systematic way by scientists like Galileo and Newton We now have a better understanding of this devastating disease that does not discriminate by age, sex or ethnicity

The molecular circuitry of a Cancer Cell..not simple! Hanahan and Weinberg, Cell 144: 646-674 (2011)

Cancer is a genetic disease Point Mutations Lung Cancer K-Ras EGFR Amplifications Neuroblastoma N-Myc Deletions Retinoblastoma Rb on 13q14 CH 3 CH 3 Translocations Leukemia Bcr-Abl Epigenetics (Methylation) Many cancers RASSF1A

Established Hallmarks of Cancer Hanahan and Weinberg, Cell 144: 646-674 (2011) Department of Pediatrics Women s and Children Health Research Institute

Emerging Hallmarks - The detrimental effect of immune cells Hanahan and Weinberg, Cell 144: 646-674 (2011) Department of Pediatrics Women s and Children Health Research Institute

Progression from Chronic Inflammation to Cancer Normal Cells Inflammed Cell Inflammed cell to Cancer Cell Cancer Cell Replication Cancer Cell Expansion (Neo-vascularization) Metastasis Tumor Burden Challenge: can we target here! Pre-condition to cancer Most drugs target here

Changes during colon cancer progression Inflammation Department of Pediatrics Women s and Children Health Research Institute

Treatment modalities for Cancer

Cancer Immunotherapy Cytostasis (cyto cell; stasis stoppage) is the inhibition of cell growth and multiplication

Immunological Synapse: Contact point of activation Nature Reviews Immunology 2007;7:599-609

Adaptive Immunity Precise Communication mechanisms http://www.biolegend.com/category_costimulatory_molecules_rat

Immunotherapy https://www.youtube.com/watch?v=k09xziq8zsg

The Future of cancer therapy https://pct.mdanderson.org/#/

Paraneoplastic antigen syndrome Paraneoplastic syndromes are typical among middle-aged to older patients, and they most commonly present with cancers of the lung, breast, ovaries or lymphatic system (a lymphoma). Sometimes, the symptoms of paraneoplastic syndromes show before the diagnosis of a malignancy, which has been hypothesized to relate to the disease pathogenesis. In this paradigm, tumor cells express tissue-restricted antigens (e.g., neuronal proteins), triggering an anti-tumor immune response which may be partially or, rarely, completely effective. in suppressing tumor growth and symptoms. Patients then come to clinical attention when this tumor immune response breaks immune tolerance and begins to attack the normal tissue expressing that (e.g., neuronal) protein in the central nervous system.

Paraneoplastic antigen syndrome

Immunotherapy

A novel about cancer Wellspring Edmonton and the Allard Lecture Series are pleased to present Dr. Siddhartha Mukherjee, Pulitzer Prize winning author of The Emperor of All Maladies and the newly released book The Gene, who will be delivering a lecture on the latest research and ideas surrounding humanity s fight against cancer. When: May 24, 2016 at 4:30 pm 7:00 pm Where: The Citadel Theatre, 9828 101A Avenue Northwest, Edmonton https://www.eventbrite.ca/e/the-changinglandscape-of-cancer-tickets-24302724102